Default Product Image

Risek®

Therapeutic Segment:

Anti-Ulcerant, Gastric acid suppressant

Generic Name:

Omeprazole

Indication

Capsules
  • 20MG
  • 40MG
Injectable
  • 40MG

Capsules

For the treatment of:

  • Gastro-Esophageal Reflux Disease (GERD).
  • Gastric and duodenal ulcer.
  • Treatment and prophylaxis of NSAID-associated ulceration.
  • Eradication of Helicobacter pylori infection associated with peptic ulcer disease.
  • Zollinger-Ellison Syndrome.
  • Dyspepsia.
  • Prophylaxis of acid aspiration.

Injectable

For patients who are unable to take oral therapy for the short-term (upto 5 days) treatment of:

  • Gastro-esophageal reflux disease.
  • Peptic ulcer disease.
  • Treatment and prophylaxis of NSAID-associated ulceration.
  • Duodenal ulcer.
  • Zollinger-Ellison syndrome.
  • Prophylaxis of acid aspiration.